JNJ
Johnson & Johnson$147.59
JNJ info0.05%ย โ€ข 24 H
Dividend Yield:3.3%
Global Rank#25
Market Cap$355.26B
YTD Performance-5.95%
P/E10.76
Revenue$85.16B
Change 7d-2.60%
SP500 BenchmarkUnderperform
P/S4.17
Earnings$35.15B

Johnson & Johnson (JNJ) Stock Overview

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

JNJ Stock Information

SymbolJNJ
Address
One Johnson & Johnson PlazaNew Brunswick, NJ 08933United States
Founded-
Trading hours9:30 AM - 4:00 PM ET
Websitehttps://www.jnj.com
Country๐Ÿ‡บ๐Ÿ‡ธ United States
Phone Number732 524 0400

Johnson & Johnson (JNJ) Price Chart

-
Value:-

Johnson & Johnson Overview: Key Details and Summary

Stock data
2023
Change
Price
$147.59
N/A
Market Cap
$355.26B
N/A
Shares Outstanding
2.41B
-8.31%
Employees
152.70K
N/A
Shareholder Equity
76.80B
3.76%
Valuation
2023
Change
P/E Ratio
10.76
N/A
P/S Ratio
4.17
N/A
P/B Ratio
4.63
N/A
P/FCF
20.67
N/A
POE
0.00
N/A
Dividends
2023
Change
Dividend Yield
3.29%
N/A
Dividend per share
4.8532
N/A
Dividend Payout Ratio
0.3323
N/A
Growth
2023
Change
ROIC
0.1314
N/A
WACC
0.0089
N/A
CAPEX
-4.01B
N/A
Return on Equity
0.4577
N/A
Earnings
2023
Change
Revenue
$85.16B
N/A
Earnings
$35.15B
N/A
Free Cash Flow
$17.18B
N/A
EPS
13.72
N/A
Earnings Yield
0.093
N/A
Gross Margin
0.6882
N/A
Operating Margin
0.2584
N/A
Net income margin
0.4128
N/A
FCF Margin
0.2018
N/A
Financial Strength
2023
Change
Total Assets
$187.38B
N/A
Total Debt
$39.66B
N/A
Cash on Hand
$23.52B
N/A
Debt to Equity
$1.44
-1.32%
Cash to Debt
0.5930
-36.68%
POE
0.0000
N/A
Current Ratio
0.9909
-26.51%
Other data
2023
Change
Buyback Yield
0.0170
N/A
ยฉ 2024 TopStocks.org
Facebook Icon
Twitter Icon
Linkedin Icon